Welch KM, Goadsby PJ (2002) Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15(3):287–295

Article  PubMed  Google Scholar 

Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193–210

Article  PubMed  Google Scholar 

Evers S, Jensen R (2011) European Federation of Neurological S. Treatment of medication overuse headache–guideline of the EFNS headache panel. Eur J Neurol 18(9):1115–1121

Article  CAS  PubMed  Google Scholar 

Peters GA, Horton BT (1951) Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin 26(9):153–161

CAS  PubMed  Google Scholar 

Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and mangement of withdrawal effect: report of 52 cases. Headache 2:214–227

Article  CAS  PubMed  Google Scholar 

Worz R (1980) Abuse and paradoxical effects of analgesic drug mixtures. Br J Clin Pharmacol 10(Suppl 2):391S–3S

PubMed  PubMed Central  Google Scholar 

Gaist D, Sindrup S, Hallas J, Gram LF (1994) Misuse of sumatriptan. Lancet 344(8929):1090

Article  CAS  PubMed  Google Scholar 

Kaube H, May A, Pfaffenrath V, Sumatriptan (1994) BMJ 308(6943):1573–1574

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48(8):1157–1168

Article  PubMed  Google Scholar 

Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57(9):1694–1698

Article  CAS  PubMed  Google Scholar 

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia (2018) ;38(1):1-211

Ashina S, Terwindt GM, Steiner TJ, Lee MJ, Porreca F, Tassorelli C et al (2023) Medication overuse headache. Nat Rev Dis Primers 9(1):5

Article  PubMed  Google Scholar 

Goadsby PJ (2006) Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2(8):401

Article  PubMed  Google Scholar 

Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43(3):179–190

Article  PubMed  Google Scholar 

Williams L, O’Connell K, Tubridy N (2008) Headaches in a rheumatology clinic: when one pain leads to another. Eur J Neurol 15(3):274–277

Article  CAS  PubMed  Google Scholar 

Wilkinson SM, Becker WJ, Heine JA (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41(3):303–309

Article  CAS  PubMed  Google Scholar 

Saengjaroentham C, Strother LC, Dripps I, Sultan Jabir MR, Pradhan A, Goadsby PJ, Holland PR (2020) Differential medication overuse risk of novel anti-migraine therapeutics. Brain 143(9):2681–2688

Article  PubMed  PubMed Central  Google Scholar 

Navratilova E, Behravesh S, Oyarzo J, Dodick DW, Banerjee P, Porreca F (2020) Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia 40(9):892–902

Article  PubMed  PubMed Central  Google Scholar 

Goadsby PJ, Dodick DW, Ailani J, Trugman JM, Finnegan M, Lu K, Szegedi A (2020) Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial. Lancet Neurol 19(9):727–737

Article  CAS  PubMed  Google Scholar 

Ailani J, Lipton RB, Goadsby PJ, Guo H, Miceli R, Severt L et al (2021) Atogepant for the Preventive treatment of Migraine. N Engl J Med 385(8):695–706

Article  CAS  PubMed  Google Scholar 

Tassorelli C, Nagy K, Pozo-Rosich P, Lanteri-Minet M, Sacco S, Nezadal T et al (2024) Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial. Lancet Neurol

Croop R, Lipton RB, Kudrow D, Stock DA, Kamen L, Conway CM et al (2021) Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. Lancet 397(10268):51–60

Article  CAS  PubMed  Google Scholar 

Ong JJ, Liu Y, Smith JH, Carr K, Goadsby PJ (eds) Patient Responses to Atogepant 60 mg Once Daily: A Post hoc Analysis of the Advance and Progress Trials. Cephalalgia; 2023: Sage Publications LTD 1 Olivers Yard, 55 City Road, London Ec1y 1SP, England

Riederer F, Marti M, Luechinger R, Lanzenberger R, von Meyenburg J, Gantenbein AR et al (2012) Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety. World J Biol Psychiatry 13(7):517–525

Article  PubMed  Google Scholar 

Riederer F, Gantenbein AR, Marti M, Luechinger R, Kollias S, Sandor PS (2013) Decrease of gray matter volume in the midbrain is associated with treatment response in medication-overuse headache: possible influence of orbitofrontal cortex. J Neurosci 33(39):15343–15349

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai TH, Chou KH, Fuh JL, Lee PL, Kung YC, Lin CP, Wang SJ (2016) Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia 36(14):1324–1333

Article  PubMed  Google Scholar 

Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M et al (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129(Pt 2):543–550

Article  PubMed  Google Scholar 

Ferraro S, Grazzi L, Mandelli ML, Aquino D, Di Fiore D, Usai S et al (2012) Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study. Pain Med 13(2):255–262

Article  PubMed  Google Scholar 

Grazzi L, Chiapparini L, Ferraro S, Usai S, Andrasik F, Mandelli ML et al (2010) Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations. Headache 50(6):998–1004

Article  PubMed  Google Scholar 

Chiapparini L, Grazzi L, Ferraro S, Mandelli ML, Usai S, Andrasik F et al (2009) Functional-MRI evaluation of pain processing in chronic migraine with medication overuse. Neurol Sci 30(Suppl 1):S71–S74

Article  PubMed  Google Scholar 

Ferraro S, Grazzi L, Muffatti R, Nava S, Ghielmetti F, Bertolino N et al (2012) In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas. Headache 52(10):1520–1534

Article  PubMed  Google Scholar 

Torta DM, Costa T, Luda E, Barisone MG, Palmisano P, Duca S et al (2016) Nucleus accumbens functional connectivity discriminates medication-overuse headache. Neuroimage Clin 11:686–693

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chanraud S, Di Scala G, Dilharreguy B, Schoenen J, Allard M, Radat F (2014) Brain functional connectivity and morphology changes in medication-overuse headache: Clue for dependence-related processes? Cephalalgia 34(8):605–615

Article  CAS  PubMed  Google Scholar 

Michels L, Christidi F, Steiger VR, Sandor PS, Gantenbein AR, Landmann G et al (2017) Pain modulation is affected differently in medication-overuse headache and chronic myofascial pain - A multimodal MRI study. Cephalalgia 37(8):764–779

Article  PubMed  Google Scholar 

Fritsche G, Frettloh J, Huppe M, Dlugaj M, Matatko N, Gaul C et al (2010) Prevention of medication overuse in patients with migraine. Pain 151(2):404–413

Article  PubMed  Google Scholar 

Simshauser K, Luking M, Kaube H, Schultz C, Schmidt S (2020) Is mindfulness-based stress reduction a Promising and feasible intervention for patients suffering from Migraine? A Randomized Controlled Pilot Trial. Complement Med Res 27(1):19–30

Article  PubMed  Google Scholar 

Wells RE, O’Connell N, Pierce CR, Estave P, Penzien DB, Loder E et al (2021) Effectiveness of Mindfulness Meditation vs Headache Education for adults with migraine: a Randomized Clinical Trial. JAMA Intern Med 181(3):317–328

Article  PubMed  Google Scholar 

Grazzi L, D’Amico D, Guastafierro E, Demichelis G, Erbetta A, Fedeli D et al (2023) Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). J Headache Pain 24(1):86

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bendtsen L, Munksgaard S, Tassorelli C, Nappi G, Katsarava Z, Lainez M et al (2014) Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 34(6):426–433

Article  CAS  PubMed  Google Scholar